3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Prostatic Neoplasms
63
Lymphoma, Large B-Cell, Diffuse
47
Lymphoma
33
Burkitt Lymphoma
27
Lymphoma, Follicular
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, Non-Hodgkin
14
Neoplasms
13
Lymphoma, B-Cell
11
Lymphoma, T-Cell, Peripheral
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Hodgkin Disease
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia
8
Recurrence
6
Prostatic Neoplasms, Castration-Resistant
6
Multiple Myeloma
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Neoplasm Metastasis
5
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Anaplastic
4
Immunoblastic Lymphadenopathy
4
Ovarian Neoplasms
3
Myasthenia Gravis
3
Melanoma
3
Lymphoma, AIDS-Related
3
Interventions
Cyclophosphamide
8
ibrutinib
5
fludarabine phosphate
5
fludarabine
5
pirtobrutinib
4
Mesna
4
obinutuzumab
3
acalabrutinib
3
Mycophenolic Acid
3
Melphalan
3
venetoclax
2
Whole-Body Irradiation
2
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Busulfan
2
Bone Marrow Transplantation
2
ARQ531
2
ricolinostat
1
idelalisib
1
idecabtagene vicleucel
1
Vincristine
1
Stem Cell Transplantation
1
Rabeprazole
1
Prednisone
1
Leukapheresis
1
Itraconazole
1
Filgrastim
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Prednisone
×
1 year
×
Clear all
NCT06564038
2026-05-14
Soundtrack-E
AstraZeneca
Phase 1/2
Recruiting
408 enrolled